Healthcare Integrated Technologies, Inc.
HITCOTCHealthcare
$0.30
+$0.00(+0.00%)
Market Cap$52835973
P/E Ratio—
52W High$0.478
52W Low$0.05
Healthcare Integrated Technologies, Inc. (HITC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HITC · earnings · updated Jun 10, 2026
Latest Earnings
Q2 FY2025Report Date: Jun 18, 2025EPS Actual
-$0.01
Revenue
—
Fiscal Period
Q2 FY2025
FY ends December
Report Date
Jun 18, 2025
After Market Close
HITC reports quarterly as a OTC-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2025 | Jun 18, 2025 | — | -$0.01 | — | — | — | — |
| — Q1 FY2025 | Mar 17, 2025 | — | -$0.01 | — | — | — | — |
| — Q4 FY2024 | Dec 18, 2024 | — | -$0.01 | — | — | — | — |
| — Q4 FY2024 | Nov 15, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2024 | Jun 20, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q1 FY2024 | Mar 18, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2023 | Dec 20, 2023 | — | -$0.00 | — | — | — | — |
| — Q4 FY2023 | Nov 13, 2023 | — | -$0.00 | — | — | — | — |
Q2 FY2025
Jun 18, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 17, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Dec 18, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 15, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
Jun 20, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2024
Mar 18, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2023
Dec 20, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 13, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2023 | $0.00 | — | $0.00 | 0 |
| Q2 FY2023 | $0.00 | — | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2025 | Jun 18, 2025 | — | $0.30 | — | — |
| — Q1 FY2025 | Mar 17, 2025 | — | $0.30 | $0.29 | -3.31% |
| — Q4 FY2024 | Dec 18, 2024 | — | $0.13 | $0.13 | -2.84% |
| — Q4 FY2024 | Nov 15, 2024 | — | $0.15 | $0.14 | -7.70% |
| — Q2 FY2024 | Jun 20, 2024 | — | $0.11 | $0.10 | -6.20% |
| — Q1 FY2024 | Mar 18, 2024 | — | $0.06 | $0.06 | -0.18% |
| — Q4 FY2023 | Dec 20, 2023 | — | $0.06 | $0.06 | -2.55% |
| — Q4 FY2023 | Nov 13, 2023 | — | $0.08 | $0.08 | -2.18% |
Q2 FY2025—
Report Date
Jun 18, 2025
EPS Beat/Miss
—
Price Before
$0.30
Price After
—
Q1 FY2025-3.31%
Report Date
Mar 17, 2025
EPS Beat/Miss
—
Price Before
$0.30
Price After
$0.29
Q4 FY2024-2.84%
Report Date
Dec 18, 2024
EPS Beat/Miss
—
Price Before
$0.13
Price After
$0.13
Q4 FY2024-7.70%
Report Date
Nov 15, 2024
EPS Beat/Miss
—
Price Before
$0.15
Price After
$0.14
Q2 FY2024-6.20%
Report Date
Jun 20, 2024
EPS Beat/Miss
—
Price Before
$0.11
Price After
$0.10
Q1 FY2024-0.18%
Report Date
Mar 18, 2024
EPS Beat/Miss
—
Price Before
$0.06
Price After
$0.06
Q4 FY2023-2.55%
Report Date
Dec 20, 2023
EPS Beat/Miss
—
Price Before
$0.06
Price After
$0.06
Q4 FY2023-2.18%
Report Date
Nov 13, 2023
EPS Beat/Miss
—
Price Before
$0.08
Price After
$0.08
Beat Rate0 / 8 quarters
Largest Move-7.70% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HITC ends December
Healthcare Integrated Technologies, Inc. (HITC) most recently reported earnings on June 18, 2025 for Q2 FY2025, posting EPS of $-0.01 (in line with the analyst consensus of —).
Each quarter, investors track HITC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HITC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HITC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HITC earnings · 4 questionsHealthcare Integrated Technologies, Inc.'s next earnings report is expected around TBD. HITC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HITC historically reports after market close (AMC).
HITC earnings datewhen is HITC earningsHITC next earnings datewhen does HITC report earningsHITC earnings calendar
▸ Source: FMP · Healthcare Integrated Technologies, Inc. SEC filings · US GAAP · Healthcare Integrated Technologies, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026